SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-413218
Filing Date
2014-11-14
Accepted
2014-11-14 16:08:32
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d784467d10q.htm 10-Q 531867
2 EX-10.1 d784467dex101.htm EX-10.1 200394
3 EX-31.1 d784467dex311.htm EX-31.1 7413
4 EX-31.2 d784467dex312.htm EX-31.2 7398
5 EX-32.1 d784467dex321.htm EX-32.1 4435
  Complete submission text file 0001193125-14-413218.txt   4172231

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cyma-20140930.xml EX-101.INS 449005
7 XBRL TAXONOMY EXTENSION SCHEMA cyma-20140930.xsd EX-101.SCH 40712
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cyma-20140930_cal.xml EX-101.CAL 58090
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cyma-20140930_def.xml EX-101.DEF 134224
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cyma-20140930_lab.xml EX-101.LAB 359769
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cyma-20140930_pre.xml EX-101.PRE 244984
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36500 | Film No.: 141224126
SIC: 2834 Pharmaceutical Preparations